Molecular Determinants of Allosteric Inhibitor Affinity and Selectivity in PDE5

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• Allosteric inhibitors offer selective protein modulation within the phosphodiesterase (PDE) family by targeting unique regulatory pockets.
• Understanding inhibitor binding mechanisms is crucial for developing targeted therapeutics.

Purpose of the Study:

• To investigate the molecular determinants of evodiamine derivative (EVO) binding to PDE5.
• To elucidate the structural basis for differential recognition of EVO in PDE6 isoforms (rod and cone).
• To provide mechanistic insights for the rational design of selective PDE inhibitors.

Main Methods:

• Integrated structural modeling, all-atom molecular dynamics (MD) simulations, and alchemical free-energy calculations.
• Systematic alanine scanning and PDE6-derived mutations to quantify residue-level contributions.
• Thermodynamic analysis to identify key residues and binding interactions (hydrogen bonds, hydrophobic contacts).

Main Results:

• Identified key residues governing EVO binding to PDE5 through a network of hydrogen bonds and hydrophobic contacts.
• Characterized structural changes in the allosteric pocket of PDE5 and the role of EVO's chemical substituents.
• Demonstrated isoform-specific effects in PDE6, with rod substitutions causing greater destabilization than cone substitutions.

Conclusions:

• Defined the energetic and structural basis for allosteric inhibition of PDE5 by EVO derivatives.
• Provided mechanistic insights into the differential recognition of EVO by PDE6 isoforms.
• Established a foundation for the rational design of novel, selective PDE inhibitors.